CurrentPartnering

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Research Reports By CurrentPartnering

Found 378 publications
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics US$ 2,995.00 US$ 2,396.00 Dec, 2014 1445 pages
Cancer Vaccine Partnering Terms and Agreements US$ 1,995.00 US$ 1,596.00 Dec, 2014 294 pages
Gene Therapy Partnering Terms and Agreements US$ 1,995.00 US$ 1,596.00 Dec, 2014 526 pages
Cancer Diagnostics Partnering Terms and Agreements US$ 2,995.00 US$ 2,396.00 Dec, 2014 1290 pages
Biota Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Forest Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Lysosomal Storage Disease Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Essilor Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Peptic Ulcer Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Esophageal Reflux Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Anika Therapeutics Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Dainippon Sumitomo Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Hospira Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Celgene Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Hypertension Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Renal Failure Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Allergic Rhinitis Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Alexion Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Baxter Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Pancreatic Cancer Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 150 pages
Infertility Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Genitourinary Symptoms Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Cosmetics Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Amgen Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Liver Cancer Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Cervical Cancer Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Common Cold Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Zeltia Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Angioedema Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Anemia Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
LFB Group Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Abbott Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Array Biopharma Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Wound Healing Partnering 2009-2014 US$ 1,795.00 US$ 1,436.00 Nov, 2014 250 pages
Spinal Cord Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 150 pages
The Medicines Company Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Sun Damage Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Companion Diagnostics Partnering Terms & Agreements US$ 1,995.00 US$ 1,596.00 Nov, 2014 455 pages
Rehabilitation Medicine Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Takeda Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Neuralgia Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Regeneron Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Morphosys Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Depression Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Osteoarthritis Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Sanofi Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Neuropathy Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Hearing Disorders Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
1 2 3 4 5 ... 8
Skip to top

News & Press-Releases by CurrentPartnering